UNSPSC 51285600: Antibacterial alcohols

This classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols

UNSPSC 51285600 Antibacterial alcohols, a Class code, reflects state and local procurement focused on pharmaceutical products, medical supplies, and over-the-counter items rather than narrowly on alcohol-based disinfectants. Recent solicitations show government buyers purchasing naloxone and drug deactivation systems, medical and first aid supplies for emergency responders, generic pharmaceuticals and OTC products through cooperative purchasing arrangements, and direct-to-manufacturer prescription fulfillment capabilities. Issuing bodies span state health and human services commissions, county health departments, city fire departments, and multistate cooperative purchasing alliances. The mix of work—from emergency medical supplies to pharmacy benefit program management—indicates the code captures a broader pharmaceutical and medical supply category than its abstract name suggests.

Activity appears concentrated in Florida and the Upper Midwest, with recent solicitations from Seminole County Florida, the City of Tampa, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving Minnesota and Oregon. The City of Tampa issued IFB 26-P-00145 for medical and first aid supplies ($700,000 estimated value) with a response deadline of March 13, 2026, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. MMCAP issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products across multiple state and local facilities, with awarded vendors providing products through authorized wholesalers by July 1, 2026. The Texas HHS Commission posted a Request for Information (HHS0017013) on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs, signaling early-stage procurement strategy development rather than imminent contract awards.